KR20110108686A - Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic - Google Patents
Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic Download PDFInfo
- Publication number
- KR20110108686A KR20110108686A KR1020100028035A KR20100028035A KR20110108686A KR 20110108686 A KR20110108686 A KR 20110108686A KR 1020100028035 A KR1020100028035 A KR 1020100028035A KR 20100028035 A KR20100028035 A KR 20100028035A KR 20110108686 A KR20110108686 A KR 20110108686A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- antioxidant
- complex
- extracts
- preparation example
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 504
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 133
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 131
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 235000013305 food Nutrition 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 title description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000004310 lactic acid Substances 0.000 claims abstract description 30
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 30
- 239000004480 active ingredient Substances 0.000 claims abstract description 29
- 241000894006 Bacteria Species 0.000 claims abstract description 28
- 239000000839 emulsion Substances 0.000 claims abstract description 17
- 244000005700 microbiome Species 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims description 19
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 238000000638 solvent extraction Methods 0.000 claims description 16
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 16
- 240000006891 Artemisia vulgaris Species 0.000 claims description 14
- 241000218645 Cedrus Species 0.000 claims description 14
- 229940018973 ecklonia cava extract Drugs 0.000 claims description 11
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 10
- 240000006079 Schisandra chinensis Species 0.000 claims description 10
- 241000332371 Abutilon x hybridum Species 0.000 claims description 9
- 240000000599 Lentinula edodes Species 0.000 claims description 9
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 9
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 9
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 9
- 235000015266 Plantago major Nutrition 0.000 claims description 9
- 235000003406 Polymnia sonchifolia Nutrition 0.000 claims description 9
- 244000134540 Polymnia sonchifolia Species 0.000 claims description 9
- 241000218206 Ranunculus Species 0.000 claims description 9
- 210000003127 knee Anatomy 0.000 claims description 9
- 244000018436 Coriandrum sativum Species 0.000 claims description 8
- 235000004347 Perilla Nutrition 0.000 claims description 8
- 244000124853 Perilla frutescens Species 0.000 claims description 8
- 235000019714 Triticale Nutrition 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 8
- 241000228158 x Triticosecale Species 0.000 claims description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 5
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 5
- 239000006000 Garlic extract Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 229940067866 dandelion extract Drugs 0.000 claims description 5
- 235000020691 dandelion extract Nutrition 0.000 claims description 5
- 235000020706 garlic extract Nutrition 0.000 claims description 5
- 229940002508 ginger extract Drugs 0.000 claims description 5
- 235000020708 ginger extract Nutrition 0.000 claims description 5
- 229940065115 grapefruit extract Drugs 0.000 claims description 5
- 229940083980 lavender extract Drugs 0.000 claims description 5
- 235000020723 lavender extract Nutrition 0.000 claims description 5
- 229940072113 onion extract Drugs 0.000 claims description 5
- 229940092258 rosemary extract Drugs 0.000 claims description 5
- 235000020748 rosemary extract Nutrition 0.000 claims description 5
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 5
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 5
- 239000002435 venom Substances 0.000 claims description 5
- 210000001048 venom Anatomy 0.000 claims description 5
- 231100000611 venom Toxicity 0.000 claims description 5
- 241001572175 Gaza Species 0.000 claims description 4
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 claims description 4
- 244000017714 Prunus persica var. nucipersica Species 0.000 claims description 4
- 230000005965 immune activity Effects 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 2
- 108010065511 Amylases Proteins 0.000 claims description 2
- 235000019418 amylase Nutrition 0.000 claims description 2
- 229940069445 licorice extract Drugs 0.000 claims description 2
- 230000003595 spectral effect Effects 0.000 claims description 2
- 239000000052 vinegar Substances 0.000 claims description 2
- 235000021419 vinegar Nutrition 0.000 claims description 2
- 239000004382 Amylase Substances 0.000 claims 1
- 241000205585 Aquilegia canadensis Species 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 244000265736 Nelumbo pentapetala Species 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 240000001462 Pleurotus ostreatus Species 0.000 claims 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims 1
- 241000245165 Rhododendron ponticum Species 0.000 claims 1
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 229940119569 wormwood extract Drugs 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 35
- 238000011282 treatment Methods 0.000 abstract description 35
- 102000004190 Enzymes Human genes 0.000 abstract description 30
- 108090000790 Enzymes Proteins 0.000 abstract description 30
- 239000000843 powder Substances 0.000 abstract description 26
- 238000004519 manufacturing process Methods 0.000 abstract description 20
- 239000007787 solid Substances 0.000 abstract description 20
- 239000007788 liquid Substances 0.000 abstract description 17
- 239000004615 ingredient Substances 0.000 abstract description 9
- 230000036542 oxidative stress Effects 0.000 abstract description 8
- 230000003712 anti-aging effect Effects 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 abstract description 7
- 231100000460 acute oral toxicity Toxicity 0.000 abstract description 4
- 230000001172 regenerating effect Effects 0.000 abstract description 4
- 235000006708 antioxidants Nutrition 0.000 description 116
- 238000002360 preparation method Methods 0.000 description 84
- 238000000605 extraction Methods 0.000 description 34
- -1 superoxide radicals Chemical class 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 33
- 239000002131 composite material Substances 0.000 description 32
- 229940088598 enzyme Drugs 0.000 description 27
- JVJFIQYAHPMBBX-UHFFFAOYSA-N HNE Natural products CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 description 25
- JVJFIQYAHPMBBX-FNORWQNLSA-N (E)-4-hydroxynon-2-enal Chemical compound CCCCCC(O)\C=C\C=O JVJFIQYAHPMBBX-FNORWQNLSA-N 0.000 description 21
- 238000001914 filtration Methods 0.000 description 17
- 239000012528 membrane Substances 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000004744 fabric Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000006071 cream Substances 0.000 description 10
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 241001512722 Ecklonia cava Species 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 8
- 239000013543 active substance Substances 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- 240000004670 Glycyrrhiza echinata Species 0.000 description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 7
- 240000005561 Musa balbisiana Species 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 210000004209 hair Anatomy 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 229940010454 licorice Drugs 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 6
- 235000003097 Artemisia absinthium Nutrition 0.000 description 6
- 240000001851 Artemisia dracunculus Species 0.000 description 6
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 6
- 240000004371 Panax ginseng Species 0.000 description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000001138 artemisia absinthium Substances 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 108010056771 Glucosidases Proteins 0.000 description 5
- 102000004366 Glucosidases Human genes 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 5
- 235000011613 Pinus brutia Nutrition 0.000 description 5
- 241000018646 Pinus brutia Species 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- LGURYBCSJPXHTF-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)ethyl benzoate Chemical compound ClC1=CC(Cl)=CC=C1OCCOC(=O)C1=CC=CC=C1 LGURYBCSJPXHTF-UHFFFAOYSA-N 0.000 description 4
- 240000002234 Allium sativum Species 0.000 description 4
- 240000004307 Citrus medica Species 0.000 description 4
- 240000000560 Citrus x paradisi Species 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 101710179684 Poly [ADP-ribose] polymerase Proteins 0.000 description 4
- 102100023712 Poly [ADP-ribose] polymerase 1 Human genes 0.000 description 4
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 4
- 241001290151 Prunus avium subsp. avium Species 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- 241000234314 Zingiber Species 0.000 description 4
- 235000006886 Zingiber officinale Nutrition 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 235000019693 cherries Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000490 cosmetic additive Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 235000004611 garlic Nutrition 0.000 description 4
- 235000008397 ginger Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000001023 inorganic pigment Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000012860 organic pigment Substances 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000234282 Allium Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 235000007862 Capsicum baccatum Nutrition 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 235000002787 Coriandrum sativum Nutrition 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000165082 Lavanda vera Species 0.000 description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 235000014443 Pyrus communis Nutrition 0.000 description 3
- 244000178231 Rosmarinus officinalis Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 239000001728 capsicum frutescens Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 239000001102 lavandula vera Substances 0.000 description 3
- 235000018219 lavender Nutrition 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000004575 stone Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 102000016679 alpha-Glucosidases Human genes 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- BOCBOJPUWMTAJB-UHFFFAOYSA-N (2-butylphenyl) 2-hydroxybenzoate Chemical compound CCCCC1=CC=CC=C1OC(=O)C1=CC=CC=C1O BOCBOJPUWMTAJB-UHFFFAOYSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- QZJDYFVPLXBWTK-UHFFFAOYSA-N 2-(diethylamino)ethyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCN(CC)CC QZJDYFVPLXBWTK-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- ZMXUPLNMYABPEB-UHFFFAOYSA-N 2-[[2-(dodecanoylamino)acetyl]amino]acetic acid Chemical compound CCCCCCCCCCCC(=O)NCC(=O)NCC(O)=O ZMXUPLNMYABPEB-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QUBNFZFTFXTLKH-UHFFFAOYSA-N 2-aminododecanoic acid Chemical compound CCCCCCCCCCC(N)C(O)=O QUBNFZFTFXTLKH-UHFFFAOYSA-N 0.000 description 1
- AKVBCGQVQXPRLD-UHFFFAOYSA-N 2-aminooctanoic acid Chemical compound CCCCCCC(N)C(O)=O AKVBCGQVQXPRLD-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- BXUZCKBEUHXHQB-UHFFFAOYSA-N 2-phenylethanesulfonyl fluoride Chemical compound FS(=O)(=O)CCC1=CC=CC=C1 BXUZCKBEUHXHQB-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ZYIFAFPFZXUPAX-UHFFFAOYSA-N 3-(dimethylamino)propyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCCN(C)C ZYIFAFPFZXUPAX-UHFFFAOYSA-N 0.000 description 1
- SDZHIRPZKXFSBX-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCC(=O)NCCC(O)=O SDZHIRPZKXFSBX-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101800004419 Cleaved form Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- PYVHTIWHNXTVPF-UHFFFAOYSA-N F.F.F.F.C=C Chemical compound F.F.F.F.C=C PYVHTIWHNXTVPF-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- WUBKCBOQNXUQDU-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone Chemical compound OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 WUBKCBOQNXUQDU-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 210000002403 aortic endothelial cell Anatomy 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000019463 artificial additive Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical class CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- NGHOLYJTSCBCGC-VAWYXSNFSA-N benzyl cinnamate Chemical group C=1C=CC=CC=1/C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-VAWYXSNFSA-N 0.000 description 1
- VZWMKHUMEIECPK-UHFFFAOYSA-M benzyl-dimethyl-octadecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 VZWMKHUMEIECPK-UHFFFAOYSA-M 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- AGNCRIYGRWNVIF-UHFFFAOYSA-N calcium;2-(dodecanoylamino)acetic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCC(O)=O AGNCRIYGRWNVIF-UHFFFAOYSA-N 0.000 description 1
- CEGYXKLZALIAEI-UHFFFAOYSA-N calcium;2-(dodecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCS(O)(=O)=O CEGYXKLZALIAEI-UHFFFAOYSA-N 0.000 description 1
- YEFORLIOCBRMFS-UHFFFAOYSA-N calcium;2-(hexadecanoylamino)ethanesulfonic acid Chemical compound [Ca].CCCCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O YEFORLIOCBRMFS-UHFFFAOYSA-N 0.000 description 1
- HOQGRRFKKLWWOO-UHFFFAOYSA-N calcium;3-(dodecanoylamino)propanoic acid Chemical compound [Ca].CCCCCCCCCCCC(=O)NCCC(O)=O HOQGRRFKKLWWOO-UHFFFAOYSA-N 0.000 description 1
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229940029991 coriander extract Drugs 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- GICLSALZHXCILJ-UHFFFAOYSA-N ctk5a5089 Chemical compound NCC(O)=O.NCC(O)=O GICLSALZHXCILJ-UHFFFAOYSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940105040 geranium extract Drugs 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000010487 meadowfoam seed oil Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical class [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 235000013522 vodka Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/34—Anti-oxidant compositions; Compositions inhibiting chemical change containing plant or animal materials of unknown composition
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The antioxidant according to the present invention consists of processed extracts obtained by bioconverting the extracts extracted from natural raw materials into enzyme-treated or enzyme-treated extracts into lactic acid bacteria or specific microorganisms, which are subjected to antioxidant activity, anti-aging activity, and oxidative stress. Has a regenerative effect on cells. In addition, it is extracted from natural raw materials and is safe for human skin and has no acute oral toxicity. In addition, antioxidants, which are decolorized and deodorized by enzyme treatment and processed extracts which are bioconverted by a specific lactic acid bacterium or a specific microorganism as an active ingredient, can be easily prepared in solid powder form, liquid form, or emulsion form during the manufacturing process. Do. In addition, the complex natural antioxidant according to the present invention is excellent in compatibility with other ingredients, and is very stable in formulation when preparing a cosmetic composition, a food composition, or a feed composition.
Description
The present invention relates to an antioxidant and its use, and more particularly, to an antioxidant including a processed extract obtained by fermentation of an enzyme-treated or an enzyme-treated extract extracted from a natural raw material selected by bioscreening and feed thereof It relates to the use as an additive, a food additive, or a cosmetic additive.
It is a known fact that our human bodies are in close contact with the external environment and are easily sensitized due to exposure to ultraviolet rays, environmental pollution, chemicals, detergents and pollen. Skin exposed by such an external environment is easily exposed to reactive oxygen species, and the generated reactive oxygen species attack normal cellular tissues or cell membranes, and the skin eventually causes inflammation. Inflammated tissues cause skin aging such as wrinkles and the like by breaking down proteins and genetic material on the skin.
In general, there are many theories explaining skin aging, but among them, the free radical theory that the skin ages due to free radicals caused by various factors in and out of the body is accepted as the most valid theory. Free radicals are chemically highly reactive chemicals that occur when the skin is irradiated with UV light or during the respiration of cells in the skin. Most of the free radicals associated with aging of the skin are Reactive Oxygen Species (ROS), which include superoxide radicals, hydrogen peroxide (H 2 O 2 ), and hydroxy radicals (Hydroxy Radical). , Singlet oxygen, and the like.
These reactive oxygen species are generated during ultraviolet irradiation or respiratory processes to cause peroxidation of lipids, which are components of cell membranes, through a multi-step chain reaction. Lipid peroxidation generates various active species such as radicals, peroxides, aldehydes, and epoxides and damages DNA, RNA, proteins, cell membranes, and cellular structures. Toxicity of these reactive oxygen species is considered to be a major cause of cancer, tissue damage, and aging (Black HS, Photochem photobiol, 46 (2), 213,1987).
Antioxidants such as tocopherol, polyphenols,
Since BHA and BHT have the same problems as described above, they are mainly used as preservatives. Until now, synthetic vitamin C is most frequently used as an antioxidant added to cosmetics. In that sense, there was a problem that it can not be used relatively safely compared to natural extracts. In addition, there have been many efforts to obtain skin aging prevention effects by adding superoxide dismutase (SOD) and vitamin E derivatives to cosmetics, but due to the limitation of concentration in actual product application due to difficulty in stabilization or poor solubility. Antioxidants known to date, such as difficult to achieve a substantial effect has been most of the problems in terms of skin safety and stability when formulating cosmetics is limited in its use.
The present invention has been made to solve the conventional problems, one object of the present invention is to reduce the side effects of the conventional synthetic antioxidant is safe for the human body, while at the same time having a high natural antioxidant properties, formulation stability and reproducibility It is to provide antioxidants. In addition, the present invention has another object to provide a use of the antioxidant in feed, food, cosmetics.
In order to solve the above object, the inventors of the present invention through bioscreening for antioxidant activity against about 2500 kinds of natural products of plant origin, as a candidate substance 칡, bean sprouts, green onions, shiitake mushrooms, mushrooms, arc Knotweed, golden, yellowish white, hwangyeon, cedar leaf, broccoli, sancho, triticale, eoseongcho, sari, sesin, shrill, pine needles, knee roots, jinjin mugwort, buttercup, ginger, venom, yacon, omija, indongcho, grapefruit, jangsaeng bellflower, Seonji, red vegetable, plantain, persimmon, sesame, bark skin, let's eat, licorice, incense, red ginseng, Seokgok, cilantro, spectators, guk gu, gujeolcho, kkujippong, golden ruler, golden cherry tree, gilkyung The present invention has been completed through the anti-oxidant effect of the combination of processed extracts obtained by screening garlic, Ecklonia cava, dandelion, white paper, and Bokryeong and enzymatically treating the extracts or fermenting the extracts.
In order to achieve the above object of the present invention, the present invention is the extract of 칡, bean sprouts extract, green onion extract, shiitake mushroom extract, chopped mushroom extract, kojang-gun extract, golden extract, baekbaek extract, sulfur extract, cedar leaf extract, brokerage extract, Sancho extract, Triticale extract, Echo extract, Prunus extract, Secinin extract, Root extract, Pine needle extract, Knee root extract, Injin mugwort extract, Buttercup extract, Ginger extract, Poison extract, Yacon extract, Schisandra extract, Indongcho extract, Grapefruit extract, One or more extracts selected from the group consisting of Jangsaeng Bellflower Extract, Geranium Extract, Red Vegetable Extract, Plantain Extract, Perilla Extract, and Sesame Extract, and Bark Extract, Garza Extract, Licorice Extract, Ginseng Extract, Red Ginseng Extract, Seokgok Extract, Coriander Extract, spectral extract, gut extract, gujeolcho extract, Selected from the group consisting of kkujippong extract, Geumjinja extract, Geumjakja extract, Gilgyeong extract, Mandang extract, Dansam extract, sugar citron extract, lavender extract, rosemary extract, garlic extract, Ecklonia cava extract, dandelion extract, white paper extract and Bokyeong extract Provided is an antioxidant comprising a second complex extract obtained by glycosidase treatment of the first complex extract comprising one or more extracts as an active ingredient. The present invention also provides an antioxidant comprising the third complex extract obtained by bioconversion of the second complex extract into a lactic acid bacterium or a specific microorganism as an active ingredient. Antioxidants according to the present invention, as well as antioxidant activity, functions to inhibit the expression of proteins known to cause oxidative stress to increase the immune activity (regenerative effect) and senescence (or apoptosis) of cells in the environment. Has The antioxidant according to the present invention may exist in various forms such as solid powder form, emulsion form, or liquid form, and is preferably in emulsion form in consideration of storage stability and ease of handling. Looking at the method of producing an antioxidant in the emulsion form according to the present invention, for example, adding an oily medium and an emulsion stabilizer to the second complex extract or the third complex extract, and emulsifying and nano-dispersing by applying a shear force.
In order to achieve the above object of the present invention, the present invention, 칡, bean sprouts, green, shiitake mushrooms, red mushrooms, Ho Jang-geun, golden, yellow white, yellow yeon, yangyangyeop, broccoli, Sancho, three hundred seconds, eoseongcho, sari, Sesin, sound At least one selected from the group consisting of bamboo shoots, pine needles, knee roots, jinjin mugwort, buttercup, ginger, venom, yacon, schisandra chinensis, indongcho, grapefruit, Jangsaeng bellflower, ghost, red pepper, plantain, perilla, and wormwood From the group consisting of licorice, incense, ginseng, Seokgok, cilantro, spectators, guk, gujeolcho, KUJIGON, golden man, golden cherry tree, Gilkyung, mandang, sweet ginseng, sugar citron, lavender, rosemary, garlic, Ecklonia cava, dandelion, white paper Obtaining an extract containing an antioxidant active ingredient by a solvent extraction method or a supercritical extraction method from an extraction raw material comprising at least one selected; Enzymatic treatment by adding and reacting glycosidase to the extract comprising the antioxidant active ingredient; Filtering the enzyme-treated extract into an extract and a residual extract raw solid; Concentrating the separated extract to obtain a second complex extract; It provides a method for producing an antioxidant comprising a. In addition, the present invention comprises the steps of forming a mixture of the second complex extract with a lactic acid bacteria medium or a specific microbial medium; Bioconverting the second complex extract by inoculating and fermenting the mixture with a lactic acid bacterium or a specific microorganism; And filtering the biologically converted second composite extract to obtain a third composite extract.
In order to achieve the above object of the present invention, the present invention provides a feed composition, a food composition or a cosmetic composition comprising the antioxidant. Since the antioxidant of the present invention has antioxidant activity, anti-aging activity, and regenerative effect of cells subjected to oxidative stress, when used as a feed additive, a food additive, or a cosmetic additive, each product has a health function due to the antioxidant activity. You can give it.
The antioxidant according to the present invention consists of processed extracts obtained by bioconverting the extracts extracted from natural raw materials into enzyme-treated or enzyme-treated extracts into lactic acid bacteria or specific microorganisms, which are subjected to antioxidant activity, anti-aging activity, and oxidative stress. Has a regenerative effect on cells. In addition, it is extracted from natural raw materials and is safe for human skin and has no acute oral toxicity. In addition, antioxidants, which are decolorized and deodorized by enzyme treatment and processed extracts which are bioconverted by a specific lactic acid bacterium or a specific microorganism as an active ingredient, can be easily prepared in solid powder form, liquid form, or emulsion form during the manufacturing process. Do. In addition, the complex natural antioxidant according to the present invention is excellent in compatibility with other ingredients, and is very stable in formulation when preparing a cosmetic composition, a food composition, or a feed composition.
1 shows the results of high performance liquid chromatography (HPLC) analysis of the second complex extract (top) and the third complex extract (bottom).
Figure 2 shows the antioxidant efficacy of the composite natural antioxidant prepared in Preparation Example 9 of the present invention.
Figure 3 is a fluorescence micrograph showing the cell regeneration effect by the composite natural antioxidant prepared in Preparation Example 9 of the present invention.
Figure 4 is a Western blot picture showing the effect of inhibiting the expression of aging-induced protein by the complex natural antioxidant prepared in Preparation Example 9 of the present invention.
One aspect of the present invention relates to an antioxidant and a method for producing the same, including extracts extracted from natural raw materials.
Antioxidant agent of the present invention is a second complex extract obtained by treating the first complex extract comprising an extract extracted from two or more natural raw materials with glycosidase or the agent obtained by bioconversion of the second complex extract to lactic acid bacteria or specific microorganisms 3 contains a complex extract as an active ingredient. Hereinafter, the antioxidant according to the present invention and a manufacturing method thereof will be described by dividing into a first complex extract, a second complex extract and a third complex extract.
First Complex Extract
The first complex extract according to the present invention, for example, 칡 extract, bean sprout extract, green onion extract, shiitake mushroom extract, chopped mushroom extract, kojang-geun extract, golden extract, baekbaek extract, sulfur extract, cedar leaf extract, broccoli extract, sancho extract , Triticale Extract, Estuary Extract, Pear Extract, Sessin Extract, Root Extract, Pine Needle Extract, Knee Root Extract, Root Worm Extract, Buttercup Extract, Ginger Extract, Poison Extract, Yacon Extract, Schisandra Extract, Indongcho Extract, Grapefruit Extract, Jangsaeng Bellflower At least one extract selected from the group consisting of extracts, germ extracts, red vegetable extracts, plantain extracts, perilla extracts, and wormwood extracts, bark skin extracts, Gaza extracts, licorice extracts, nectarine extracts, red ginseng extracts, stone extracts, coriander extracts, Spectrum extract, gut extract, gujeolcho extract, kkujippong 1, selected from the group consisting of extract, Geumja extract, Geumjakja extract, Giltyeong extract, Mandang extract, Dansam extract, Sacrose extract, Lavender extract, Rosemary extract, Garlic extract, Ecklonia cava extract, Dandelion extract, White paper extract and Bokryeong extract Extracts of species or more. In addition, the first complex extract includes cedar leaf extract, triticale extract, Eungchocho extract, Injin mugwort extract, and optionally Ecklonia cava extract.
In addition, the first complex extract includes a cedar leaf extract, three hundred vine extract, Eungchocho extract, and jinjin mugwort extract, preferably the first composite extract further comprises Ecklonia cava extract. When the first complex extract includes Ecklonia cava extract, the antioxidant activity of the antioxidant is further increased. The content in the complex extract of each extract extracted from each natural raw material is not particularly limited, generally 20 to 200 parts by weight, 300 to 200 parts by weight, 20 to 200 parts by weight of Echo extract, Injin mugwort extract 20 ˜200 parts by weight and optionally 20-200 parts by weight of Ecklonia cava extract.
Description of the main raw material of the first complex extract according to the present invention is as follows. Fish herbaceous perennial herbaceous species belonging to more than three hundred, mainly distributed in Korea and Japan, grow in the mountains, or in shady and wet land. Eoseongcho is named after its fishy fishy smell. The three hundred perennial herbaceous perennial plant is a perennial herb of more than three hundred dicotyledonous plants. Three hundred seconds is the name given because the roots, leaves, and flowers are white. Injin mugwort is a perennial plant of the dicotyledon plant Lantern Asteraceae, mainly distributed in Korea, Japan, China, etc., and often grows in sandy lands near streams. It is an evergreen juniper tree of the dicotyledon azalea, Rhododendron, which is distributed mainly in Mt. Baekdu, Korea and eastern Siberia, and grows under the forest of high mountains. Ecklonia cava is a perennial seaweed with brown seaweed kelp, seaweed, distributed mainly in the south coast of Korea and Japan, and grows deep in the lunch. Other raw materials are omitted from the description.
The composite extract according to the present invention includes various antioxidant active substances, antimicrobial active substances and the like contained in the extract raw material as the active substance. The active substances are mainly flavonoids, polyphenols or terpenes, specifically quercitrin, isoquercitrin, quercetin, rutin, myrcene, myrcene, Mircetin, Seanol, methyl-N-nonene, bacalin, bacicalein, and the like, but are not limited thereto.
The method for producing the first composite extract according to the present invention is 칡, bean sprouts, green onion, shiitake mushrooms, red mushrooms, Ho Jang Geun, golden, yellow white, yellow yeon, yang hyang leaf, broccoli, Sancho, three hundred seconds, Eoseongcho, sari, Sesin, sound At least one selected from the group consisting of bamboo shoots, pine needles, knee roots, jinjin mugwort, buttercup, ginger, venom, yacon, schisandra chinensis, indongcho, grapefruit, Jangsaeng bellflower, ghost, red pepper, plantain, perilla, and wormwood From the group consisting of licorice, incense, ginseng, Seokgok, cilantro, spectators, guk, gujeolcho, KUJIGON, golden man, golden cherry tree, Gilkyung, mandang, sweet ginseng, sugar citron, lavender, rosemary, garlic, Ecklonia cava, dandelion, white paper Obtaining an extract containing an antioxidant active ingredient by a solvent extraction method or a supercritical extraction method from an extraction raw material comprising at least one selected; And filtering the extract comprising the antioxidant active ingredient into an extract and a residual extract raw solid; and concentrating the separated extract to obtain a first complex extract.
In addition, the method for producing a first composite extract according to the present invention is an extract containing an antioxidant active ingredient by a solvent extraction method, or a supercritical extraction method from the extract raw material containing the cedar leaf, three hundred vine, Eochocho, phosphorus mugwort, and optionally Ecklonia cava Obtaining a; And filtering the extract comprising the antioxidant active ingredient into an extract and a residual extract raw solid; and concentrating the separated extract to obtain a first complex extract.
Looking at the solvent extraction method, the solvent used may be water, alcohol having 1 to 5 carbon atoms, ethyl acetate, chloroform, acetone, 1,2-hexanediol, 1,3-butanediol, butylene glycol, water It is also possible to use a mixed solvent in which at least one selected from the remaining solvents is mixed. Of these, considering the hazards to the human body, it is preferable that the solvent is a mixed solvent of water, an alcohol having 1 to 5 carbon atoms or a mixture of water and an alcohol having 1 to 5 carbon atoms. The extraction temperature of the solvent extraction method is not particularly limited, and is preferably characterized in that 40 ~ 80 ℃. If the extraction temperature is less than 40 ℃ extraction rate to extraction yield is low, and if the extraction temperature exceeds 80 ℃ there is a fear that the extracted active ingredient is deformed by heat. In addition, the use ratio of the extraction raw material to the extraction solvent is not particularly limited, and typically, about 300 to 1000 parts by weight of the extraction solvent is used based on 100 parts by weight of the extraction raw material. Extraction time typically requires about 1 to 3 hours, but is not limited thereto.
In addition, the first complex extract according to the present invention may be preferably extracted by a supercritical extraction method. When the supercritical extraction method is used, the extraction yield is higher than that of the solvent extraction method, and the first composite extract extracted by the supercritical extraction method reduces odor and increases the transparency of the liquid form (or the size of the color) than that extracted by the solvent extraction method. Is reduced). The supercritical extraction method uses a mixture of 1 to 20 parts by weight of an auxiliary solvent with respect to 100 parts by weight of carbon dioxide as a main solvent as a reaction medium, wherein diethylamine or triethylamine is methanol, ethanol, water, 1, It is composed of an alkaline cosolvent dissolved in 2 to 20% (vol%, v / v) in 2-hexanediol, 1,3-butanediol, butylene glycol, or a mixed solvent thereof. In supercritical extraction, extraction temperature is about 70 ~ 90 ℃ and extraction pressure is about 4000 ~ 6000 PSI.
Extracts extracted by solvent extraction or supercritical extraction are separated into extracts and residual extract raw solids by a filter cloth or filter paper having a pore size of micrometers, wherein the extract is concentrated to form a first complex extract in liquid form. In addition, the concentrated first complex extract may be prepared as a first complex extract in powder form by drying. At this time, the drying method is not limited in kind, but is preferably lyophilized in order to minimize the thermal deformation of the active ingredient. On the other hand, the residual extract raw material solid may be used to extract the active ingredient again by solvent extraction or supercritical extraction.
2nd complex extract
The second composite extract according to the present invention, for example, 칡 extract, bean sprout extract, green onion extract, shiitake mushroom extract, chopped mushroom extract, kojang-geun extract, golden extract, baekbaek extract, sulfur extract, cedar leaf extract, brokerage extract, Sancho extract , Triticale Extract, Estuary Extract, Pear Extract, Sessin Extract, Root Extract, Pine Needle Extract, Knee Root Extract, Root Worm Extract, Buttercup Extract, Ginger Extract, Poison Extract, Yacon Extract, Schisandra Extract, Indongcho Extract, Grapefruit Extract, Jangsaeng Bellflower At least one extract selected from the group consisting of extracts, germ extracts, red vegetable extracts, plantain extracts, perilla extracts, and wormwood extracts, bark skin extracts, Gaza extracts, licorice extracts, nectarine extracts, red ginseng extracts, stone extracts, coriander extracts, Spectrum extract, gut extract, gujeolcho extract, kkujippong 1, selected from the group consisting of extract, Geumja extract, Geumjakja extract, Giltyeong extract, Mandang extract, Dansam extract, Sacrose extract, Lavender extract, Rosemary extract, Garlic extract, Ecklonia cava extract, Dandelion extract, White paper extract and Bokryeong extract A first complex extract comprising extracts of at least one species is obtained by treatment with glycosidase.
In addition, the second complex extract according to the present invention is obtained by enzymatic treatment of the first complex extract, including the cedar leaf extract, three hundred vine extract, Echo vinegar extract, Injin mugwort extract, and optionally Ecklonia cava extract.
In this case, the first complex extract provided for the enzyme treatment may use a concentrated form in the manufacturing process or may use a solid powder form. An enzyme used in enzyme treatment is glycosidase, and glycosidase is also called glycoside hydrolase, and has a function of hydrolyzing glycoside bonds of glycosides or small sugars. In the present invention, when the glycosidase treatment, the extraction raw material itself can be decomposed to make the extraction easier and the extraction yield can be increased, and the extraction of various active ingredients can be performed to increase the antioxidant activity of the complex extract. have. In addition, glycosidase treatment serves to deodorize and decolorize the extract by decomposing off-flavor or color components contained in the extract extracted by solvent extraction or supercritical extraction. Moreover, the removal of impurities by the membrane filter which mentions glycosidase treatment later is made smooth.
Method for producing a second complex extract according to the present invention, 칡, bean sprouts, green onion, shiitake mushrooms, red mushrooms, Ho Jang Geun, golden, yellow white, yellow yeon, yangyangyeop, brokerage, Sancho, three hundred vine, Eoseongcho, sari, Sesin, sound At least one selected from the group consisting of bamboo shoots, pine needles, knee roots, jinjin mugwort, buttercup, ginger, venom, yacon, schisandra chinensis, indongcho, grapefruit, Jangsaeng bellflower, ghost, red pepper, plantain, perilla, and wormwood From the group consisting of licorice, incense, ginseng, Seokgok, cilantro, spectators, guk, gujeolcho, KUJIGON, golden man, golden cherry tree, Gilkyung, mandang, sweet ginseng, sugar citron, lavender, rosemary, garlic, Ecklonia cava, dandelion, white paper Obtaining an extract containing an antioxidant active ingredient by a solvent extraction method or a supercritical extraction method from an extraction raw material comprising at least one selected; Enzymatic treatment by adding and reacting glycosidase to the extract comprising the antioxidant active ingredient; Filtering the enzyme-treated extract into an extract and a residual extract raw solid; And concentrating the separated extract to obtain a second complex extract.
In addition, the method for producing a second complex extract according to the present invention is an extract containing an antioxidant active ingredient by a solvent extraction method, or a supercritical extraction method from the extract raw material including cedar leaf, three hundred vine, Eochocho, phosphorus mugwort, and optionally Ecklonia cava Obtaining a; Enzymatic treatment by adding and reacting glycosidase to the extract comprising the antioxidant active ingredient; Filtering the enzyme-treated extract into an extract and a residual extract raw solid; And concentrating the separated extract to obtain a second complex extract.
The type of glucosidase used is not particularly limited, and specifically, amylae, cellulase, xylanase, galactose, lactase, maltase (maltase) or mixed enzymes thereof, and the like, and are preferably amylases. Commercially available glucosidases include Viscozyme ® , Econase ® , Fungamyl ® , Sebamyl ® , and Clariceb ® .
The reaction temperature, reaction pH, and reaction time of the first complex extract for glucosidase treatment vary depending on the enzyme used. Typically, the reaction temperature is 40-60 ° C., the reaction pH is 4-6, and the reaction time is 1-. 3 hours. In addition, the amount of enzyme is about 0.1 ~ 1 parts by weight based on 100 parts by weight of the extraction raw materials in consideration of economics such as enzyme processing time, enzyme cost.
Extracts treated with glucosidase are separated into extracts and residual extract solids by filtration, where filtration separates the extracts into extracts and residual extract solids by filter cloth or filter paper with a pore size of micrometers. And the primary filtered extract is filtered with a membrane filter having a pore size of nanometers to remove impurities (odor component or color component). Glucosidase is difficult to perform due to the large load when filtration of the extract passed through the filter cloth or filter paper from the extract raw material by solvent extraction method or supercritical extraction method with a membrane filter having a pore size of nanometers. Enzymatically treated and primary filtered extract is easily filtered by the membrane filter, the odor or components that contribute to the color can be removed. The filtrate obtained by filtration in the glycosidase treated extract is concentrated to form a second complex extract in liquid form. In addition, the concentrated second complex extract may be prepared in powder form by drying. At this time, the drying method is not particularly limited, but is preferably lyophilized in order to minimize thermal deformation of the active ingredient. On the other hand, the residual extract raw material solid may be used to extract the active ingredient again by solvent extraction or supercritical extraction.
Third Complex Extract
The third complex extract according to the present invention, for example, 칡 extract, bean sprouts extract, green onion extract, shiitake mushroom extract, chopped mushroom extract, kojang-gun extract, golden extract, baekbaek extract, sulfur extract, cedar leaf extract, brokerage extract, Sancho extract , Triticale Extract, Estuary Extract, Pear Extract, Sessin Extract, Root Extract, Pine Needle Extract, Knee Root Extract, Root Worm Extract, Buttercup Extract, Ginger Extract, Poison Extract, Yacon Extract, Schisandra Extract, Indongcho Extract, Grapefruit Extract, Jangsaeng Bellflower At least one extract selected from the group consisting of extracts, germ extracts, red vegetable extracts, plantain extracts, perilla extracts, and wormwood extracts, bark skin extracts, Gaza extracts, licorice extracts, nectarine extracts, red ginseng extracts, stone extracts, coriander extracts, Spectrum extract, gut extract, gujeolcho extract, kkujippong 1, selected from the group consisting of extract, Geumja extract, Geumjakja extract, Giltyeong extract, Mandang extract, Dansam extract, Sacrose extract, Lavender extract, Rosemary extract, Garlic extract, Ecklonia cava extract, Dandelion extract, White paper extract and Bokryeong extract The second complex extract obtained by treating the first complex extract including the extract of species or more with glycosidase is obtained by bioconversion by lactic acid bacteria or a specific microorganism.
In addition, the third complex extract according to the present invention is characterized in that the second complex extract obtained by treating the first complex extract, including cedar leaf extract, triticale extract, Echochocho extract, Injin mugwort extract, and optionally Ecklonia cava extract with glycosidase Obtained by bioconversion by lactic acid bacteria or specific microorganisms.
In this case, lactic acid bacteria or the second complex extract provided for a specific microorganism fermentation may use a concentrated form in the manufacturing process or may use a solid powder form. The lactic acid bacteria or specific microorganisms used for bioconversion of the second complex extract are not particularly limited as long as they are harmless to the human body, and specifically, Lactobacillus and Streptococcus , Pediococcus, Leuconostoc and the like.
When the second complex extract is bioconverted by lactic acid bacteria or specific microbial fermentation, various active substances are produced to increase the antioxidant activity of the complex extract. In addition, compatibility with other ingredients is increased when preparing a feed composition, a food composition, or a cosmetic composition including an antioxidant in the form of an emulsion or a complex natural antioxidant, which will be described later, thereby improving stability of the formulation.
Looking at the method for producing a third complex extract according to the present invention, forming a mixture of the second complex extract with lactic acid bacteria medium or a specific microbial medium; Bioconverting the second complex extract by inoculating and fermenting the mixture with a lactic acid bacterium or a specific microorganism; And filtering the bioconverted second composite extract to obtain a third composite extract. In this case, when the second complex extract used to prepare the third complex extract is subjected to nanofiltration by a membrane filter in the manufacturing process, the filtration of the step of obtaining the third complex extract is a filter cloth or filter paper having a pore size in micrometers. Filtration by is sufficient. On the other hand, when the second complex extract used to prepare the third complex extract is not subjected to nanofiltration by the membrane filter in the manufacturing process, the filtration of the step of obtaining the third complex extract is a filter cloth having a pore size of micrometer unit or It is preferred to consist of primary filtration with filter paper and secondary filtration with membrane filter with pore size in nanometers. The third complex extract obtained by filtration can then be prepared as a third complex extract in concentrated liquid form, and the concentrated third complex extract can also be prepared in powder form by drying. At this time, the drying method is not limited in kind, but is preferably lyophilized in order to minimize the thermal deformation of the active ingredient.
The complex natural antioxidant according to the present invention may also be composed of the second complex extract or the third complex extract itself, and preferably the storage stability, processability into the formulation, other ingredients in the product, so long as the antioxidant activity is not inhibited. Various auxiliary additives may be further included in order to improve compatibility, and the like. In addition, the complex natural antioxidant may be present in liquid form, in solid powder form, or in emulsion form, and is preferably in emulsion form in view of storage stability and ease of handling. Method of producing a complex natural antioxidant in the form of an emulsion includes, for example, adding an oily medium and an emulsion stabilizer to the second complex extract or the third complex extract and emulsifying by applying shear force.
There are various types of auxiliary additives to be used depending on the purpose of the auxiliary additives, specifically glycerin (Clycerin), caster oil (Gaster), glycine (Glycine), Tween (Dextrin), Lactic acid (Lactic acid) ).
Another aspect of the invention relates to the use of said complex natural antioxidant.
Complex natural antioxidant according to the present invention is composed of extracts of various natural raw materials, has a high antioxidant effect, anti-aging effect, safety for human skin, and non-toxic during acute oral administration, and other whitening effects derived from natural products It has effects such as wrinkle improvement, anti-inflammatory action, atopy improvement, acne healing. Therefore, the antioxidant according to the present invention can be used for the purpose of improving immune function or enhancing cell regeneration, anti-aging, etc. in various products such as pharmaceutical compositions, cosmetic compositions, food compositions, or feed compositions. When the complex natural antioxidant according to the present invention is applied to a pharmaceutical composition, a cosmetic composition, a food composition, or a feed composition, the content thereof is not particularly limited, and the content may be appropriately selected in consideration of toxicity. For example, when the complex natural antioxidant according to the present invention is applied to the cosmetic composition, the amount thereof is preferably about 0.05 to 5.0 wt% based on the total weight of the product, and when used in a food composition, the amount thereof is used as the total amount of the product. 0.01 to 2.0% by weight is preferred based on the weight.
Hereinafter, the case in which the complex natural antioxidant according to the present invention is applied to the cosmetic composition will be described in more detail. Those skilled in the art to which the present invention pertains will be able to produce a cosmetic composition comprising the complex natural antioxidant of the present invention by selecting suitable formulations and additives as is well known. Specific examples of the cosmetic composition that can be prepared include various creams, lotions, skins, shampoos, rinses, cleansing agents, face washes, soaps, treatments, essences, and the like, and specific examples of face wash creams, face wash foams, cleansing creams, cleansing milks, and cleansing lotions. , Massage cream, cold cream, moisturizing cream, latex, lotion, pack, aftershave cream, sunburn prevention cream, suntan oil, soap, body shampoo, hair shampoo, hair rinse, hair treatment, wool, hair care, hair Cream, hair liquid, set lotion, hair spray, hair bridge, coloring, color spray, permanent wave liquid, press powder, loose powder, eye shadow, hand cream, lipstick and the like.
The cosmetic composition including the complex natural antioxidant of the present invention includes an aqueous vitamin, an oily vitamin, a polymer peptide, a polymer polysaccharide, a sphingolipid, and the like.
The aqueous vitamin may be any compound that can be incorporated into the cosmetic composition, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H and the like. And salts thereof (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) can also be used in the present invention. Included in
The oil-based vitamin may be any compound that can be blended into the cosmetic composition, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-α-tocopherol, d-α-tocopherol, d-δ-tocopherol) and the like. And derivatives thereof (ascorbic palmitate, ascorbic stearate, ascorbic palmitate, acetic acid dl-α-tocopherol, dl-α-tocopherol vitamin E, DL-pantothenyl alcohol, D-pantothenyl). Alcohols, pantotenylethyl ether, etc.) are also included in the oil-soluble vitamins used in the present invention.
The polymer peptide may be any compound as long as it can be incorporated into the cosmetic composition. Preferably, collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin, and the like can be given.
The polymer polysaccharide may be any compound as long as it can be blended into the cosmetic composition. Preferably, hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned. For example, chondroitin sulfate or its salt can be normally purified from a mammal or fish.
The sphingolipid may be any compound as long as it can be blended into the cosmetic composition. Preferably, ceramide, pit spingosine, sphingoglycolipid and the like can be given.
Moreover, you may mix | blend with the said cosmetic composition the other component normally mix | blended with a cosmetics as needed with the said component. Examples of the blending component that may be added include oils and fats, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, antioxidants, plant extracts, pH adjusters, alcohols, pigments, flavors, and the like. .
Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.
Examples of the moisturizing agent include a water-soluble low molecular moisturizer, a fat-soluble molecular moisturizer, a water-soluble polymer, and a fat-soluble polymer.
Examples of the emollient include long-chain acyl glutamic acid cholesteryl esters, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl esters, and the like.
As surfactant, nonionic surfactant, anionic surfactant, cationic surfactant, amphoteric surfactant, etc. are mentioned. Nonionic surfactants include self-emulsifying glycerin monostearate, propylene glycol fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, sorbitan fatty acid esters, POE (polyoxyethylene) sorbitan fatty acid esters, POE sorbitan fatty acid esters, POE Glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE-POP (polyoxyethylene-polyoxypropylene) copolymer, POE-POP alkyl ether, polyether modified silicone, lauric acid Alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid, etc. are mentioned. As anionic surfactant, fatty acid soap, (alpha)-acyl sulfonate, alkyl sulfonate, alkyl allyl sulfonate, alkyl naphthalene sulfonate, alkyl sulfate, POE alkyl ether sulfate, alkylamide sulfate, alkyl phosphate, POE alkyl phosphorus salt, alkylamide Phosphates, alkyloylalkyltaurine salts, N-acylamino acid salts, POE alkyl ether carboxylate salts, alkyl sulfosuccinate salts, sodium alkyl sulfo acetates, acylated hydrolyzed collagen peptide salts, perfluoroalkyl phosphate esters, and the like. have. As cationic surfactant, alkyl trimethylammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, cetostearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, stearyl dimethyl benzyl ammonium bromide, behenyl trimethyl ammonium chloride, chloride Benzalkonium, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like. Examples of amphoteric surfactants include carboxybetaine type, amidebetaine type, sulfobetaine type, hydroxysulfobetaine type, amide sulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type and amideamine type. An amphoteric surfactant etc. are mentioned.
Organic and inorganic pigments include silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengala, clay, bentonite, titanium film mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, aluminum oxide Inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine blue, chromium oxide, chromium hydroxide, calamine, carbon black, and composites thereof; Polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene, styrene copolymer, Organic pigments such as silk powder, cellulose, CI pigment yellow, CI pigment orange, and composite pigments of these inorganic pigments and organic pigments;
As organic powder, Metal soaps, such as a calcium stearate; Alkyl phosphate metal salts such as sodium cetylinate, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-β-alanine calcium, N-lauroyl-β-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-acyl basic amino acids, such as N (epsilon) -lauroyl-L- lysine, N (epsilon) -palmitolysine, N (alpha)-partoylol nitin, N (alpha)-lauroyl arginine, and N (alpha) -cured fatty acid acyl arginine; N-acyl polypeptides, such as N-lauroyl glycyl glycine; α-amino fatty acids such as α-aminocaprylic acid and α-aminolauric acid; Polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride and the like.
Examples of the ultraviolet absorber include paraaminobenzoic acid, ethyl paraaminobenzoate, amyl paraaminobenzoic acid, octyl paraaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentyl salicylate and cinnamic acid benzyl , Paramethoxy cinnamic acid 2-ethoxyethyl, paramethoxy cinnamic acid octyl, diparamethoxy cinnamic acid mono 2-ethylhexane glyceryl, paramethoxy cinnamic acid isopropyl, diisopropyl diisopropyl cinnamic acid ester mixture, urokanoic acid Ethyl urocanate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and salts thereof, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenonedisulfonate, dihydroxybenzophenone, tetra Hydroxybenzophenone, 4-tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxy) -1,3 , 5-triazine, 2- (2-hydroxy 5-methylphenyl) benzotriazole and the like.
Examples of the alcohol include higher alcohols such as cetyl alcohol.
In addition, the complex natural antioxidant of the present invention can be applied to a functional food composition because it can anticipate the effects of biological defense, prevention of disease, recovery of disease or inhibition of aging by providing antioxidant efficacy. The application to the functional food composition is not particularly limited in form, and may be specifically applied to ice cream, powdered milk, yogurt, health drinks and alcohol (vodka and other alcoholic beverages). In addition, the complex natural antioxidant of the present invention can be applied to feed compositions, pharmaceutical compositions, etc., wherein each composition can be prepared with ingredients and formulations commonly used in the art.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples are only intended to more clearly describe the present invention, and do not limit the protection scope of the present invention.
1. Preparation of Complex Extracts and Characteristics of Complex Extracts
(1) Preparation of the first composite extract from natural raw materials
Production Example 1
50 kg of dried fruit, 50 kg of Schisandra chinensis, 50 kg of Gujeolcho and 50 kg of Dandelion were added to the extraction reactor, and 1000 kg of water was added to the extraction solvent. The temperature of the extraction reactor was maintained at about 80 ℃ for 3 hours to extract the antioxidant active ingredient of natural raw materials. The extract was filtered with a filter cloth to separate the extract and the remaining extract raw solids, and the filtered extract was concentrated to a concentration of about 2.0 Brix using a reduced pressure evaporator to obtain 140 kg of the first complex extract in the form of a concentrate. In addition, the first complex extract in the form of a concentrate was lyophilized to obtain a first complex extract in the form of a powder.
Production Example 2
40 kg of dried cedar leaves, 40 kg of dried trichophyte, 40 kg of dried fish herb, 40 kg of dried mulberry leaf, and 40 kg of dried Ecklonia cava were added thereto, and 1000 kg of water was added thereto as an extraction solvent. The temperature of the extraction reactor was maintained at about 80 ℃ for 3 hours to extract the antioxidant active ingredient of natural raw materials. The extract was filtered with a filter cloth to separate the extract and the remaining extract raw solid, and the filtered extract was concentrated to a concentration of about 2 Brix using a reduced pressure evaporator to obtain 140 kg of the first complex extract in the form of a concentrate. In addition, the first complex extract in the form of a concentrate was lyophilized to obtain a first complex extract in the form of a powder.
(2) Preparation of Second Composite Extract from Natural Raw Materials
Preparation Example 3.
50 kg of dried fruit, 50 kg of Schisandra chinensis, 50 kg of Gujeolcho and 50 kg of Dandelion were added to the extraction reactor, and 1000 kg of water was added to the extraction solvent. The temperature of the extraction reactor was maintained at about 80 ℃ for 3 hours to extract the antioxidant active ingredient of natural raw materials. After lowering the temperature of the extraction reactor to about 55 ℃ and adjusting the pH of the extract to about 5.5, the extract is charged with about 200 g of glycosidase (Fungamyl ® , Sebamyl ® , and Clariseb ® ; Special Enzyme, USA) for 3 hours After the reaction, the temperature of the extract was raised to about 80 ° C. to inactivate the enzyme. The enzyme-treated extract was first filtered through a filter cloth to separate the extract and the remaining extract raw material solids, and then the filtered extract was passed through a membrane filter (pore size: 0.45 μm) and filtered secondly to remove impurities using a reduced pressure evaporator. Components that contribute to color, odor, etc.) were removed. The extract passed through the membrane filter was concentrated to a concentration of about 2.5 Brix to give 140 kg of the second complex extract in the form of a concentrate. In addition, the second complex extract in the form of a concentrate was lyophilized to obtain a second complex extract in the form of a powder.
Preparation Example 4.
40 kg of dried cedar leaves, 40 kg of dried trichophyte, 40 kg of dried fish herb, 40 kg of dried mulberry leaf, and 40 kg of dried Ecklonia cava were added thereto, and 1000 kg of water was added thereto as an extraction solvent. The temperature of the extraction reactor was maintained at about 80 ℃ for 3 hours to extract the antioxidant active ingredient of natural raw materials. After lowering the temperature of the extraction reactor to about 55 ℃ and adjusting the pH of the extract to about 5.5, the extract is charged with about 200 g of glycosidase (Fungamyl ® , Sebamyl ® , and Clariseb ® ; Special Enzyme, USA) for 3 hours After the reaction, the temperature of the extract was raised to about 80 ° C. to inactivate the enzyme. The enzyme-treated extract was first filtered through a filter cloth to separate the extract and the remaining extract raw material solids, and then the filtered extract was passed through a membrane filter (pore size: 0.45 μm) and filtered secondly to remove impurities using a reduced pressure evaporator. Components that contribute to color, odor, etc.) were removed. The extract passed through the membrane filter was concentrated to a concentration of about 2.5 Brix to give 140 kg of the second complex extract in the form of a concentrate. In addition, the second complex extract in the form of a concentrate was lyophilized to obtain a second complex extract in the form of a powder.
(3) Preparation of the third composite extract
Preparation Example 5.
1 L of LB variable medium (Luria-Bertani media) and 94 L of the second complex extract in the form of a concentrate obtained in Preparation Example 3 were added thereto, and the fermenter was sterilized by steam. The temperature of the sterilized fermenter was maintained at 40 ° C, and 5 l of lactic acid bacteria culture solution was added to the fermenter to inoculate. The inoculated lactic acid culture medium was precultured with Lactobacillus bacteria in LB variable media (Luria-Bertani media), and the cell count concentration of lactic acid bacteria was 1 × 10 7 cfu (Colony Forming Unit) / ml. LB medium was used consisting of 10 g / L tryptone, 10 g / L sodium chloride (NaCl), 5 g / l yeast extract on the distilled water base.
The temperature of the fermenter inoculated with the lactic acid bacteria culture medium was adjusted to about 35 ° C. and fermented for about 12 hours to bioconvert the second composite extract. Thereafter, the fermentation broth of the fermenter was filtered sequentially using a filter cloth and a membrane filter to obtain 100 kg of the third complex extract in liquid form. In addition, it was concentrated and dried to obtain a third complex extract in powder form.
Preparation Example 6.
1 L of LB variable medium (Luria-Bertani media) and 94 L of the second complex extract in the form of a concentrate obtained in Preparation Example 4 were added, and the fermenter was sterilized by steam. The temperature of the sterilized fermenter was maintained at 40 ° C, and 5 l of lactic acid bacteria culture solution was added to the fermenter to inoculate. At this time, the inoculated lactic acid bacteria cultured Lactobacillus (Lactobacillus) bacteria in LB medium (Luria-Bertani media) preculture (Preculture), the number of cells of lactic acid bacteria concentration of 1 × 10 7 cfu (Colony Forming Unit) / ㎖ The LB variable medium was composed of 10 g / l tryptone, 10 g / l sodium chloride (NaCl) and 5 g / l yeast extract on distilled water base.
The temperature of the fermenter inoculated with the lactic acid bacteria culture medium was adjusted to about 35 ° C. and fermented for about 12 hours to bioconvert the second composite extract. Thereafter, the fermentation broth of the fermenter was filtered sequentially using a filter cloth and a membrane filter to obtain 100 kg of the third complex extract in liquid form. In addition, it was concentrated and dried to obtain a third complex extract in powder form.
(4) Characteristics of Complex Extract
1) Color and Odor Evaluation of Complex Extracts
The color and smell of the solvent extract of the natural raw material, the enzyme-treated extract treated with the enzyme extract and the enzyme-treated extract, and the extract obtained by bioconversion of the enzyme-treated extract by lactic acid bacteria fermentation were observed. The composite extract in powder form prepared by Preparation Example 2, Preparation Example 4, and Preparation Example 6 was dissolved in distilled water to a concentration of 2.5% (w / v), and color and smell were observed. In the case of color, Preparation Example 2 had a deep navy blue, Preparation Example 4 had a dark yellow color, Preparation Example 6 had a light yellow color. In addition, in the case of the smell, in Preparation Example 2 was strong off odor inherent in the extraction raw material, in the case of Preparation Example 4 and Preparation Example 6 almost no off-flavor. From the above results, it can be seen that the complex extract extracted with the solvent is decolorized and deodorized through the enzyme treatment and the fermentation treatment.
2) Changes in Active Substances of the Third Complex Extract Bioconverted by Lactic Acid Bacteria or Specific Microbial Fermentation
High performance liquid chromatography (HPLC) analysis was carried out to observe the active substances of the second and third complex extracts in powder form obtained in Preparation Examples 4 and 6. As a mobile phase solvent, acetonitrile and 0.5% of phosphoric acid (Phosphoric acid) were mixed at 27:73 (v / v). The column was a u-Bondapak C18 silica column. It was used to dissolve the extract in the form of distilled water. 1 shows the results of high performance liquid chromatography (HPLC) analysis of the second complex extract (top) and the third complex extract (bottom). As shown in Figure 1 it can be seen that the rich active material is produced by lactic acid bacteria fermentation.
3) Evaluation of antioxidant efficacy of the second complex extract and the third complex extract
Antioxidant efficacy of the second complex extract and the third complex extract in powder form obtained in Preparation Example 4 and Preparation Example 6 was measured using the DPPH (1,1-diphenyl-2-picrylhydrazyl) method. DPPH is a colored radical that can be used to directly determine the radical removal capacity of a sample. The second complex extract and the third complex extract in powder form obtained in Preparation Example 4 and Preparation Example 6 were dissolved in a solvent (ethanol), respectively, to prepare a sample having 100 µg / ml (converted at w / v% concentration of 0.01%). 1 ml of 100 uM DPPH was mixed with 1 ml of the sample, followed by reaction at room temperature for 30 minutes. Absorbance was measured at 517 nm to determine the amount of DPPH remaining, and the relative antioxidant effect of each sample was expressed as a percentage of radical scavenging activity relative to the control group (control group: test group consisting of DPPH and solvent only, without sample). In addition, as a comparative example, the radical scavenging capacity of ascorbic acid was measured, and the experimental results are shown in Table 1. As shown in Table 1, the second complex extract and the third complex extract according to the present invention showed a high antioxidant effect over ascorbic acid, and particularly, the highest antioxidant activity in the third complex extract in which abundant active substances were produced by lactic acid bacteria fermentation. It showed an effect.
2. Preparation and Characteristics of Complex Natural Antioxidants Containing Third Complex Extract
(1) Preparation of Complex Natural Antioxidants
Preparation Example 7 (Preparation of Natural Antioxidant in Powder Form)
A small amount of glycine (Glycine) was added to the third complex extract of the liquid form obtained in Preparation Example 6 as a buffering agent, concentrated, and concentrated by drying with a spray dryer or a lyophilizer. Natural antioxidants were prepared.
Preparation Example 8 (Preparation of Natural Antioxidant in Liquid Form)
A small amount of glycerin and dextrin was added to the third complex extract of the liquid form obtained in Preparation Example 6, dissolved, and then the pH was adjusted to 5.0 with lactic acid to prepare a complex natural antioxidant in liquid form. Prepared.
Preparation Example 9 (Preparation of Natural Antioxidant in Emulsion Form)
The third complex extract in liquid form obtained in preparation 6 was concentrated to about 2.5 Brix. 18 kg of the third complex extract concentrated in the emulsification tank. 60 kg of glycerin and 22 kg of castor oil were added thereto, and the temperature of the emulsifying tank was increased to about 70 to 75 ° C., and homogenized by stirring with a homogenizer (about 220 to 250 rpm). . Thereafter, the temperature of the emulsion tank was lowered to about 32 to 35 ° C., and the pH of the content homogenized with lactic acid was adjusted to about 3 to 5 to prepare a complex natural antioxidant in the form of an emulsion.
(2) Evaluation of Antioxidant Efficacy of Complex Natural Antioxidants
DPPH (1,1-diphenyl-2-picrylhydrazyl) method was used to confirm the antioxidant effect of the composite natural antioxidant prepared in Preparation Example 9. DPPH is a colored radical that can be used to directly determine the radical removal capacity of a sample. Samples (complex natural antioxidants and comparative samples prepared in Preparation Example 9) were dissolved in a solvent (ethanol) and prepared for each concentration. 1 ml of each sample was mixed with 1 ml of 100 uM DPPH, followed by 30 minutes at room temperature. Reacted. Absorbance was measured at 517 nm to determine the amount of DPPH remaining, and the relative antioxidant effect of each sample was expressed as a percentage of radical scavenging activity relative to the control group (control group: test group consisting of DPPH and solvent only, without sample).
Figure 2 shows the antioxidant efficacy of the composite natural antioxidant prepared in Preparation Example 9 of the present invention. As shown in FIG. 2, the composite natural antioxidant prepared in Preparation Example 9 of the present invention showed higher antioxidant activity than polyphenol, green butylated hydroxyanisole (BHA), and butylated hydroxytoluene (BHT) of green tea powder. From these antioxidant activity results, it can be seen that the complex natural antioxidant prepared in Preparation Example 9 of the present invention can be used as a food additive, a cosmetic additive, a feed additive, a pharmaceutical additive, and the like.
(3) Cell Regeneration Effect of Complex Natural Antioxidants (Cell Recovery Test)
1) Cell Culture
Incubate Bovine aortic endothelial cells (BAEC; supplied by Kyushu University, Japan) with Dulbecco's Modified Eagle medium (DMEM, GIBCO BRL, Grand Island, NY) containing 10% fetal calf serum (FCS, GIBCO BRL) (37 ° C., 5% CO 2 ).
2) Treatment of Cultured Cells
BAEC cells cultured for 24 hours were treated with 0.2 μM 4-HNE (4-Hydroxynonenal, oxidant) and incubated for 12 hours. After 12 hours of incubation with 4-HNE, the cells were washed well to remove the oxidant, and then cultured again. The complex natural antioxidant prepared in Preparation Example 9 (dissolved in ethanol was adjusted to 10 μg / ml) was added thereto, and the cells were harvested after 12 hours or 24 hours of incubation.
3) Cell state change measurement
Harvested cells were stained with 100 μg / ml acridine orange (Sigma Chemical Co.) and 100 μg / ml ethidium bromide (Sigma Chemical Co.) in 35 mm Acas dishes (Mat-Tek, USA). It was observed under a microscope (reflected fluorescence microscopy; Olympus, Japan). The cells that appear green when viewed under a fluorescence microscope are living cells and those cells that are observed in red are cells that have apoptosis.
Figure 3 is a fluorescence micrograph showing the cell regeneration effect by the composite natural antioxidant prepared in Preparation Example 9 of the present invention. In FIG. 3, "A" was cultured without 4-HNE treatment and the complex natural antioxidant treatment prepared in Preparation Example 9, and "B" was cultured with 4-HNE for 12 hours, and "C". Was treated for 12 hours with 4-HNE and then cultured for 12 hours with the complex natural antioxidant prepared in Preparation Example 9, "D" is a complex natural prepared in Preparation Example 9 after 12 hours treatment with 4-HNE. It was incubated for 24 hours with antioxidants. As shown in FIG. 3, when the complex natural antioxidant prepared in Preparation Example 9 was treated to cells subjected to oxidative stress with 4-HNE, the immune activity of the cells was increased, such as the cells of the control group not treated with oxidative stress. It can be seen that is recovered. Therefore, when the complex natural antioxidant prepared in Preparation Example 9 of the present invention is used as feed additives, functional food additives, etc. of livestock, the immune activity of the livestock or human body is increased to increase disease resistance, and in the case of livestock, the increase of the individual is expected. Could be.
(4) Anti-aging Effect of Complex Natural Antioxidants
1) Cell Culture
Bovine pulmonary artery endothelial cells [BPAE; Korean Cell Line Bank (supplied from KCLB0, Korea) was incubated with Dulbecco's Modified Eagle medium (DMEM, GIBCO BRL, Grand Island, NY) containing 10% fetal calf serum (FCS, GIBCO BRL) (37 ° C). , 5% CO 2 ).
2) Treatment of Cultured Cells
BPAE cells cultured for 24 hours were treated with 0.2 μM 4-HNE (4-Hydroxynonenal, oxidant) and incubated for 6 hours. After 12 hours of incubation with 4-HNE, the cells were washed well to remove the oxidant, and then cultured again. The complex natural antioxidant prepared in Preparation Example 9 (dissolved in ethanol was adjusted to 10 μg / ml) was added thereto, and the cells were harvested after 12 hours or 24 hours of incubation.
3) Western blot anaylsis
Western blot was used to analyze the expression level of PARP cleaved form of harvested cells. PARP fragment proteins are known as protein forms that increase expression upon induction of apoptosis. After culturing, the cells were removed from the incubator, washed twice with cold PBS, 1 ml of PBS was added to the culture dish, and the cells were removed with a scraper. The cells were transferred to a centrifuge tube and centrifuged (3000 rpm, 3 min, 4 ° C.), and then the supernatant was discarded and 1 μg / ml aprotinin and 100 μg / ml phenylmethylmethylsulfonyl fluoride (PMSF) lysis buffer (1%). Protein was extracted with Triton X-100.50 mM Tris-HCL, 150 mM NaCl, 0.2% sodium azide) and centrifuged at 12,000 rpm for 10 minutes to separate the protein extract. The concentration of the isolated protein was measured by BSA assay (Bicinichonic acid solution), and 20-40 µg of protein was electrophoresed on 12% SDS-polyacrylamide gel. The protein on the electrophoretic gel was transferred to a polyvinylidene difluoride (PVDF) membrane at 280 mA for 90 minutes, and the membrane was washed with TBST (0.1% Tween-Tris-buffered saline) and blocked at room temperature for 1 hour with 5% skim milk. The primary antibody (dilution ratio 1: 2000) was reacted at room temperature for 2 hours, washed three times with TBST for 10 minutes, and then reacted with HRP-conjugated secondary antibody (dilution ratio: 10000) for 1 hour. After the antibody reaction was completed, the membrane was washed 4 times with TBST for 1 minute, and the formed immune complexes were identified using ECL (enhanced chemiluminescence) coloring reagent.
Figure 4 is a Western blot picture showing the effect of inhibiting the expression of aging-induced protein by the complex natural antioxidant prepared in Preparation Example 9 of the present invention. In FIG. 4, "A" is treated for 6 hours with 4-HNE and then cultured for 12 hours with the complex natural antioxidant prepared in Preparation Example 9, and "B" is prepared after 6 hours with culture for 4HNE. 24 hours treatment culture with the complex natural antioxidant prepared in 9, "C" is 6 hours treatment culture with 4-HNE, "D" is the 4-HNE treatment and the complex natural antioxidant prepared in Preparation Example 9 as a control It was cultured without first treatment. As shown in FIG. 4, treatment of the complex natural antioxidant prepared in Preparation Example 9 to cells subjected to oxidative stress with 4-HNE inhibited the intracellular expression of PARP fragment protein known as a protein associated with aging. Can be. On the other hand, it can be seen that a large amount of PARP fragment protein is expressed in cells subjected to oxidative stress with 4-HNE. Therefore, when the composite natural antioxidant prepared in Preparation Example 9 of the present invention is used as feed additives, functional food additives, functional cosmetic additives, etc. of livestock, it may be expected to not only increase immunity due to antioxidant of livestock or human body but also inhibit aging. .
(5) Acute Oral Toxicity Evaluation of Complex Natural Antioxidants
An acute oral toxicity test was conducted to confirm whether the complex natural antioxidant prepared in Preparation Example 9 can be safely applied to food, medicine, and the like. Twenty five to six week old SPF SD rats were used as an experimental animal under the acute toxicity test under the following conditions.
ㆍ Temperature and humidity conditions: Temperature 22 ± 2 ℃.
ㆍ Contrast cycle: Fluorescent lamp lighting (lights up at 08, lights out at 20)
ㆍ Roughness: 200 to 300 Lux
ㆍ Free drinking water treated with ultraviolet rays
ㆍ Dilute the test substance in sterile distilled water to prepare a sample for administration.
On the day of administration, the general condition is observed every hour up to 4 hours, and once a day from the day after the administration, the general condition changes, poisoning symptoms, mobility, appearance, autonomic nerves, and the presence of dead animals are carefully observed. Pathological anatomical verification was performed to determine the toxicity. The half lethal dose (LD 50 ) was higher than 20ml / kg body weight (BW), and it was determined that there was no toxicity.
(6) Safety evaluation of human natural skin of complex natural antioxidants
In order to confirm whether the complex natural antioxidant prepared in Preparation Example 9 is safe for human skin, skin safety verification experiment was performed. As a test method, a skin cumulative stimulation test was performed. 0.1% (w / v), 1% (w / v), 5% (w / v) and 10% (w / v) were added to the composite natural antioxidant prepared in Preparation Example 9 based on squalene, respectively. A skin external preparation was prepared and used to determine whether complex natural antioxidants irritated the skin by subjecting 30 healthy adults to cumulative patching on the upper forearm for a total of nine 24 hours every other day. . The patching method used a fin chamber (Finn chamber, Epitest Ltd, Finland). 15 µl of each of the external preparations for skin was added dropwise to the chamber, followed by patching. As a result of the measurement, the composite natural antioxidant prepared in Preparation Example 9 of the present invention did not show a distinct cumulative stimulation pattern, and was found to be safe for human skin.
In addition, 30 subjects were subjected to a patch test on the upper arm using an IQ chamber. Psoriasis, eczema, and other skin lesion holders, or those who are pregnant, nursing or contraceptives, and antihistamines, were excluded from this study. Wipe the test site with 70% ethanol and dry it, and then prepare samples of the composite natural antioxidant 1% (w / v) and
※ Criteria for Determination of Skin Response in Table 2
1) Negative (-): No irritation
2) Doubtful or slight reaction and erythema (±): Mild erythema that can be detected as unstimulated faint or barely
3) Erythema + Induration (+): Mild erythema, edema and papules with pronounced hard stimulus boundaries
4) Erythema + Induration + Vesicle (++): Measles, erythema, papules and vesicles
5) Erythema + Induration + Bullae (+ + +): Strong stimulation Severe erythema, Alveolar vesicles, Skin formation
In addition, if the mean score is 0.00-0.75, it is non-irritating, 0.76-1.50 is non-irritating, 1.51-2.50 is light stimulation, 2.51-4.00 is medium stimulation, and 4.01 or more is determined as strong stimulation.
3. Feed compositions, food compositions, including complex natural antioxidants, and Cosmetics Preparation of the composition
Production Example 10. (Animal Feed Composition Production Example)
Animal feed composition comprising a composite natural antioxidant prepared in Preparation Example 9 was prepared in the composition of Table 3.
Preparation Example 11 (Drinking Food Composition Preparation Example)
The beverage food composition containing the composite natural antioxidant prepared in Preparation Example 9 was prepared in the composition of Table 4.
Production Example 10. (Care cream cosmetic composition production example)
Care cream containing a composite natural antioxidant prepared in Preparation Example 9 was prepared in the composition of Table 5.
Preparation Example 11 (Toner Cosmetic Composition Preparation Example)
Toner including the composite natural antioxidant prepared in Preparation Example 9 was prepared in the composition shown in Table 6.
In addition to the feed composition, food composition, and cosmetic composition, the antioxidant according to the present invention may be applied to a pharmaceutical composition and the like to exhibit a high antioxidant effect, an increase in immunity, and an anti-aging function.
In FIG. 3, "A" was cultured without 4-HNE treatment and the complex natural antioxidant treatment prepared in Preparation Example 9, and "B" was cultured with 4-HNE for 12 hours, and "C". Is treated with 12 hours of 4-HNE incubation culture and then 12 hours of incubation with the complex natural antioxidant prepared in Preparation Example 9, "D" is 12 hours of incubation treatment with the 4-HNE complex natural prepared in Preparation Example 9 It was incubated for 24 hours with antioxidants. In FIG. 4, "A" is treated for 6 hours with 4-HNE and then cultured for 12 hours with the complex natural antioxidant prepared in Preparation Example 9, and "B" is prepared after 6 hours with culture for 4HNE. 24 hours treatment culture with the complex natural antioxidant prepared in 9, "C" is 6 hours treatment culture with 4-HNE, "D" is the 4-HNE treatment and the complex natural antioxidant prepared in Preparation Example 9 as a control It was cultured without first treatment.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100028035A KR20110108686A (en) | 2010-03-29 | 2010-03-29 | Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100028035A KR20110108686A (en) | 2010-03-29 | 2010-03-29 | Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110108686A true KR20110108686A (en) | 2011-10-06 |
Family
ID=45026177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100028035A KR20110108686A (en) | 2010-03-29 | 2010-03-29 | Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110108686A (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101396842B1 (en) * | 2012-01-18 | 2014-05-19 | (주)비타바이오 | Fermentation product of schisandra chinensis and antibacterial and immune enhancing composition comprising the same |
KR101426058B1 (en) * | 2012-04-30 | 2014-07-31 | 태림상사 (주) | Preparation method of natural bathing composition |
KR101458758B1 (en) * | 2014-05-02 | 2014-11-12 | (재)남해마늘연구소 | Garlic extract with the effect of skin whithening and anti-oxient, manufacturing method htereof and cosmetic composition comprising the same |
CN104435753A (en) * | 2014-11-20 | 2015-03-25 | 王正琦 | Sugar-free traditional Chinese medicinal buccal tablet for treating sphagitis |
CN105147569A (en) * | 2015-10-16 | 2015-12-16 | 孟红琳 | Antioxidation composition for cosmetics and temperature-sensitive gel |
CN105147584A (en) * | 2015-09-24 | 2015-12-16 | 广州环亚化妆品科技有限公司 | Traditional-Chinese-medicine-ingredient-containing yeast fermentation material, preparing method thereof and application thereof |
KR20160006938A (en) | 2014-07-10 | 2016-01-20 | 참자연주식회사 | Preparing method for cosmetic composition |
KR20160061494A (en) * | 2014-11-21 | 2016-06-01 | (주) 에이티바이오 | Feed for improving immunity and manufacturing method for the feed |
KR20160109953A (en) * | 2015-03-13 | 2016-09-21 | 바이허브 주식회사 | Cosmetic composition having anti-itching effect containing crude drug extracts |
KR20160109951A (en) * | 2015-03-13 | 2016-09-21 | 바이허브 주식회사 | Cosmetic composition for removal the dead skin cell containing crude drug extracts |
KR101898187B1 (en) * | 2017-05-11 | 2018-09-12 | 주식회사 비비씨 | A method for producing a complex extract having antioxidant and anticancer activity based on the raw material of Mulberry, Gugija and Omija |
KR101949153B1 (en) * | 2018-08-13 | 2019-02-18 | 충남대학교산학협력단 | A pharmaceutical composition comprising viscozyme treated extract of Morus alba leaves for preventing or treating diabetes mellitus |
WO2019124593A1 (en) * | 2017-12-21 | 2019-06-27 | 탑월드(주) | Natural cosmetic composition |
KR20190108520A (en) * | 2018-03-14 | 2019-09-24 | 정연옥 | Composition with antimicrobial or antifungal activity comprising dryopteris crassirhizoma nakai extract, salvia miltiorrhiza bunge extract and scutellaria baicalensis extract and method for preaparing the same |
KR20200019355A (en) * | 2018-08-14 | 2020-02-24 | 이중신 | Feed for poultry additive and its production method |
KR20200073313A (en) * | 2018-12-13 | 2020-06-24 | (주) 에이텍 | Cosmetic composition containing sarcodon aspratus and magnolia liliflora buda fermented extract using Yusung hot spring water |
KR20200094979A (en) * | 2019-01-31 | 2020-08-10 | 주식회사 네이쳐프렌들리 | Natural smell perfect lock and feed composition for companion animal containing the same |
KR102168732B1 (en) * | 2020-04-14 | 2020-10-22 | 김영아 | Method for manufacturing pig feed mixed pine needle extract |
KR20200138550A (en) * | 2019-05-31 | 2020-12-10 | (주)에코파낙스 | Cosmetic composition for ameliorating skin whitening and wrinkle comprising fermented Sophora flavescens extract as effective component |
KR102223084B1 (en) * | 2020-06-26 | 2021-03-04 | 김진우 | Antimicrobial immune-enhancing livestock feed additives using myrrh and gold and antimicrobial immune-enhancing livestock feed additives prepared using the same |
KR102362106B1 (en) * | 2021-03-19 | 2022-02-14 | 주식회사 현대바이오랜드 | Method for preparing fermented dendrobium candidum flower and cosmetic composition comprising the fermented dendrobium candidum flower |
KR20220067980A (en) * | 2020-11-18 | 2022-05-25 | 한밭대학교 산학협력단 | Composition for antioxidant and immunity improvement activity containing natural extracts and health functional food containing the same |
CN115211564A (en) * | 2022-07-27 | 2022-10-21 | 广州合诚三先生物科技有限公司 | Composition with natural antioxidant and antiseptic effects and preparation method thereof |
KR20220148339A (en) * | 2014-05-30 | 2022-11-04 | 카아길, 인코포레이팃드 | Method of feeding an animal |
KR20230025207A (en) * | 2021-08-13 | 2023-02-21 | (주) 팜젠사이언스 | Composition for improving immune system comprising natural plant mixture extracts and its use |
-
2010
- 2010-03-29 KR KR1020100028035A patent/KR20110108686A/en not_active Application Discontinuation
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101396842B1 (en) * | 2012-01-18 | 2014-05-19 | (주)비타바이오 | Fermentation product of schisandra chinensis and antibacterial and immune enhancing composition comprising the same |
KR101426058B1 (en) * | 2012-04-30 | 2014-07-31 | 태림상사 (주) | Preparation method of natural bathing composition |
KR101458758B1 (en) * | 2014-05-02 | 2014-11-12 | (재)남해마늘연구소 | Garlic extract with the effect of skin whithening and anti-oxient, manufacturing method htereof and cosmetic composition comprising the same |
KR20220148339A (en) * | 2014-05-30 | 2022-11-04 | 카아길, 인코포레이팃드 | Method of feeding an animal |
KR20160006938A (en) | 2014-07-10 | 2016-01-20 | 참자연주식회사 | Preparing method for cosmetic composition |
CN104435753A (en) * | 2014-11-20 | 2015-03-25 | 王正琦 | Sugar-free traditional Chinese medicinal buccal tablet for treating sphagitis |
KR20160061494A (en) * | 2014-11-21 | 2016-06-01 | (주) 에이티바이오 | Feed for improving immunity and manufacturing method for the feed |
KR20160109953A (en) * | 2015-03-13 | 2016-09-21 | 바이허브 주식회사 | Cosmetic composition having anti-itching effect containing crude drug extracts |
KR20160109951A (en) * | 2015-03-13 | 2016-09-21 | 바이허브 주식회사 | Cosmetic composition for removal the dead skin cell containing crude drug extracts |
CN105147584A (en) * | 2015-09-24 | 2015-12-16 | 广州环亚化妆品科技有限公司 | Traditional-Chinese-medicine-ingredient-containing yeast fermentation material, preparing method thereof and application thereof |
CN105147569B (en) * | 2015-10-16 | 2018-01-19 | 广州丽彦妆生物科技有限公司 | A kind of antioxidant composition and temperature sensitive hydrogel for cosmetics |
CN105147569A (en) * | 2015-10-16 | 2015-12-16 | 孟红琳 | Antioxidation composition for cosmetics and temperature-sensitive gel |
KR101898187B1 (en) * | 2017-05-11 | 2018-09-12 | 주식회사 비비씨 | A method for producing a complex extract having antioxidant and anticancer activity based on the raw material of Mulberry, Gugija and Omija |
WO2019124593A1 (en) * | 2017-12-21 | 2019-06-27 | 탑월드(주) | Natural cosmetic composition |
KR20190108520A (en) * | 2018-03-14 | 2019-09-24 | 정연옥 | Composition with antimicrobial or antifungal activity comprising dryopteris crassirhizoma nakai extract, salvia miltiorrhiza bunge extract and scutellaria baicalensis extract and method for preaparing the same |
KR101949153B1 (en) * | 2018-08-13 | 2019-02-18 | 충남대학교산학협력단 | A pharmaceutical composition comprising viscozyme treated extract of Morus alba leaves for preventing or treating diabetes mellitus |
KR20200019355A (en) * | 2018-08-14 | 2020-02-24 | 이중신 | Feed for poultry additive and its production method |
KR20200073313A (en) * | 2018-12-13 | 2020-06-24 | (주) 에이텍 | Cosmetic composition containing sarcodon aspratus and magnolia liliflora buda fermented extract using Yusung hot spring water |
KR20200094979A (en) * | 2019-01-31 | 2020-08-10 | 주식회사 네이쳐프렌들리 | Natural smell perfect lock and feed composition for companion animal containing the same |
KR20200138550A (en) * | 2019-05-31 | 2020-12-10 | (주)에코파낙스 | Cosmetic composition for ameliorating skin whitening and wrinkle comprising fermented Sophora flavescens extract as effective component |
KR102168732B1 (en) * | 2020-04-14 | 2020-10-22 | 김영아 | Method for manufacturing pig feed mixed pine needle extract |
KR102223084B1 (en) * | 2020-06-26 | 2021-03-04 | 김진우 | Antimicrobial immune-enhancing livestock feed additives using myrrh and gold and antimicrobial immune-enhancing livestock feed additives prepared using the same |
KR20220067980A (en) * | 2020-11-18 | 2022-05-25 | 한밭대학교 산학협력단 | Composition for antioxidant and immunity improvement activity containing natural extracts and health functional food containing the same |
KR102362106B1 (en) * | 2021-03-19 | 2022-02-14 | 주식회사 현대바이오랜드 | Method for preparing fermented dendrobium candidum flower and cosmetic composition comprising the fermented dendrobium candidum flower |
KR20230025207A (en) * | 2021-08-13 | 2023-02-21 | (주) 팜젠사이언스 | Composition for improving immune system comprising natural plant mixture extracts and its use |
CN115211564A (en) * | 2022-07-27 | 2022-10-21 | 广州合诚三先生物科技有限公司 | Composition with natural antioxidant and antiseptic effects and preparation method thereof |
CN115211564B (en) * | 2022-07-27 | 2024-08-16 | 广州合诚三先生物科技有限公司 | Composition with natural antioxidation and antiseptic effects and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110108686A (en) | Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic | |
KR20110096102A (en) | Antimicrobial composition with extracts of natural materials, naturotics and manufacturing method thereof | |
KR20110108687A (en) | Skin whitening agent containing extracts of natural materials and composition of cosmetic | |
JP4205188B2 (en) | Maillard reaction inhibitor | |
JP3966922B2 (en) | Fibroblast growth promoter | |
JP3966924B2 (en) | Fibroblast growth promoter containing plant extract | |
WO2011099665A1 (en) | Antimicrobial composition containing extracts from natural ingredients, natural composite antiseptics, and method for manufacturing same | |
KR101851623B1 (en) | A cosmetic composition comprising spirulina extract for blue light interception | |
WO2001026670A1 (en) | Skin-care agents, skin antiaging agents, whitening agents and external skin preparations | |
JP2007186457A (en) | Tryptase activity inhibitor and its utilization | |
JP2003095913A (en) | Cosmetic composition or food and drink | |
KR20200057677A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
JP2006022006A (en) | Sphingolipid-containing composition for cosmetic and health | |
JP4100911B2 (en) | Glutamate decarboxylase activator | |
JP5758174B2 (en) | Antioxidants and antioxidant cosmetics | |
KR100715485B1 (en) | Cosmetic composition comprising the root extract of nymphaea tetragona having skin whitening and anti-aging activity | |
JP2017214349A (en) | Cosmetic and Oral Composition | |
JP4033808B2 (en) | Beauty / health material containing Himefuuro extract | |
JP2002363088A (en) | Elastase activity inhibitor or cosmetic composition | |
JP2011026282A (en) | Hair cosmetic using biosurfactant | |
JP2002316937A (en) | Plant extract-containing anti-allergic agent | |
JP2005089355A (en) | Isomaltooligosaccharide-containing ameliorant for indigenous skin bacterial flora | |
KR20140076240A (en) | Cosmetic composition for improving atopy dermatitis containing fermented herb extract | |
JP2004238310A (en) | Cosmetic composition, drink or food | |
KR101921518B1 (en) | A cosmetic composition comprising fermented spirulina extract for antioxydant and skin winkle improvement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E601 | Decision to refuse application |